Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Cerilliant
Merck
Farmers Insurance
McKesson
Citi
Julphar
Colorcon
Healthtrust

Generated: January 21, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Cannabidivarin

« Back to Dashboard

US Patents for Cannabidivarin

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Cannabidivarin ➤ Try a Free Trial Systems and methods for producing organic cannabis tincture ➤ Try a Free Trial
Cannabidivarin ➤ Try a Free Trial Phytocannabinoids in the treatment of cancer GW Pharma Limited (Salisbury, GB) Otsuka Pharmaceutical Co., Limited (Tokyo, JP) ➤ Try a Free Trial
Cannabidivarin ➤ Try a Free Trial Methods and compositions for treating cancer Sutter West Bay Hospitals (San Francisco, CA) ➤ Try a Free Trial
Cannabidivarin ➤ Try a Free Trial Breeding, production, processing and use of specialty cannabis Biotech Institute LLC (Los Angeles, CA) ➤ Try a Free Trial
Cannabidivarin ➤ Try a Free Trial Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy GW Pharma Limited (Cambridge, GB) Otsuka Pharmaceutical Co., Limited (Tokyo, JP) ➤ Try a Free Trial
Cannabidivarin ➤ Try a Free Trial Breeding, production, processing and use of specialty Cannabis Biotech Institute, LLC (Westlake Village, CA) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Cannabidivarin

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
Cannabidivarin Argentina 080454 2030-03-12 ➤ Try a Free Trial
Cannabidivarin Australia 2011225837 2030-03-12 ➤ Try a Free Trial
Cannabidivarin Australia 2016266059 2030-03-12 ➤ Try a Free Trial
Cannabidivarin Brazil 112012023017 2030-03-12 ➤ Try a Free Trial
Cannabidivarin Canada 2792722 2030-03-12 ➤ Try a Free Trial
Cannabidivarin China 102869356 2030-03-12 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
UBS
Mallinckrodt
Teva
Harvard Business School
Deloitte
Cipla
McKinsey
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: